Effect of CD47 Blockade on Vascular Inflammation | NEJM
Cells | Free Full-Text | Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes
EHA Library - The official digital education library of European Hematology Association (EHA)
New Research on Magrolimab Provides Key Insights as Gilead Rapidly Expands Research in AML | Leukemia and Lymphoma Society
EHA Library - The official digital education library of European Hematology Association (EHA)
Magrolimab + Azacitidine vs Venetoclax in AML
CD47-SIRPα Drug Target Minireview - Drug Hunter
Forty Seven: Early Indications Suggest Magrolimab Could Be A Winner (NASDAQ:FTSV) | Seeking Alpha
PhI/II AZA/VEN/MAG - Slideset Download - | CCO
Magrolimab Demonstrates Clinical Responses in Ongoing Phase 1b Trial of Previously Untreated Acute Myeloid Leukemia Patients | Leukemia and Lymphoma Society
Magrolimab + Aza for AML - Slideset Download - Clinical Oncology 2022 | CCO
Frontiers | Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma | Future Oncology
Forty Seven: Buy The Dip In This CD47 Pioneer Ahead Of ASCO GI (NASDAQ:FTSV) | Seeking Alpha
FDA Lifts Partial Clinical Hold on MDS and AML Magrolimab Studies | Business Wire
Corporate Overview
Forty Seven: Buy The Dip In This CD47 Pioneer Ahead Of ASCO GI (NASDAQ:FTSV) | Seeking Alpha
Forty Seven, Inc. Announces Updated Data from Ongoing Clinical Trial of Magrolimab Showing Robust, Durable Activity in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia-CliniExpert
Guidance for transfusion management in patients receiving magrolimab therapy (anti‐CD47 monoclonal antibody) - Tan - 2022 - Internal Medicine Journal - Wiley Online Library
Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients
Magrolimab for Solid Tumors Clinical Trial 2023 | Power
Magrolimab combination with azacitidine enhances therapeutic... | Download Scientific Diagram
A Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients with Relapsed/Refractory Multiple Myeloma - ScienceDirect
New directions for emerging therapies in acute myeloid leukemia: the next chapter | Blood Cancer Journal
